Search Results - Neal I. Lindeman
- Showing 1 - 20 results of 91
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
Targeted Next-Generation Sequencing Reveals Clinically Actionable <i>BRAF</i> and <i>ESR1</i> Mutations in Low-Grade Serous Ovarian Carcinoma by Elizabeth H. Stover, Colleen M. Feltmate, Ross S. Berkowitz, Neal I. Lindeman, Ursula A. Matulonis, Panagiotis A. Konstantinopoulos
Published 2018Artigo -
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
Precision of Pyrosequencing Assay to Measure LINE-1 Methylation in Colon Cancer, Normal Colonic Mucosa, and Peripheral Blood Cells by Natsumi Irahara, Katsuhiko Nosho, Yoshifumi Baba, Kaori Shima, Neal I. Lindeman, Aditi Hazra, Eva Schernhammer, David J. Hunter, Charles S. Fuchs, Shuji Ogino
Published 2010Artigo -
14
Mutational landscape of goblet cell carcinoids and adenocarcinoma ex goblet cell carcinoids of the appendix is distinct from typical carcinoids and colorectal adenocarcinomas by Melanie Johncilla, Matthew D. Stachler, Joseph Misdraji, Mikhail Lisovsky, Masato Yozu, Neal I. Lindeman, Gregory Y. Lauwers, Robert D. Odze, Amitabh Srivastava
Published 2018Artigo -
15
SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma by David L. Kolin, Fei Dong, Michele Baltay, Neal I. Lindeman, Laura E. MacConaill, Marisa R. Nucci, Christopher P. Crum, Brooke E. Howitt
Published 2018Artigo -
16
Treatment-Related Toxicities in a Phase II Trial of Dasatinib in Patients with Squamous Cell Carcinoma of the Lung by Andrew M. Brunner, Daniel B. Costa, Rebecca S. Heist, Elizabeth Garcia, Neal I. Lindeman, Lynette M. Sholl, Geoffrey R. Oxnard, Bruce E. Johnson, Peter S. Hammerman
Published 2013Artigo -
17
-
18
Autocrine Production of Amphiregulin Predicts Sensitivity to Both Gefitinib and Cetuximab in <i>EGFR</i> Wild-type Cancers by Kimio Yonesaka, Kreshnik Zejnullahu, Neal I. Lindeman, Alison J. Homes, David M. Jackman, Feng Zhao, Andrew M. Rogers, Bruce E. Johnson, Pasi A. Jänne
Published 2008Artigo -
19
Validation of a targeted next-generation sequencing approach to detect mismatch repair deficiency in colorectal adenocarcinoma by David Papke, Jonathan A. Nowak, Matthew B. Yurgelun, Alexander Frieden, Amitabh Srivastava, Neal I. Lindeman, Lynette M. Sholl, Laura E. MacConaill, Fei Dong
Published 2018Artigo -
20
<i>EGFR</i>Mutation Is a Better Predictor of Response to Tyrosine Kinase Inhibitors in Non–Small Cell Lung Carcinoma Than FISH, CISH, and Immunohistochemistry by Lynette M. Sholl, Yun Xiao, Victoria A. Joshi, Beow Y. Yeap, Leigh‐Anne Cioffredi, David M. Jackman, Charles Lee, Pasi A. Jänne, Neal I. Lindeman
Published 2010Artigo
Search Tools:
Related Subjects
Medicine
Biology
Cancer
Internal medicine
Genetics
Oncology
Cancer research
Pathology
Gene
Lung cancer
Mutation
Bioinformatics
Adenocarcinoma
Computational biology
Epidermal growth factor receptor
Colorectal cancer
Receptor
Precision medicine
KRAS
Gefitinib
Genome
Breast cancer
Clinical trial
Targeted therapy
Biochemistry
Computer science
Family medicine
Tyrosine kinase
Chromosome
Guideline